Table 1.
Characteristics of hospitalized heart failure patients, by sex and year (1995 and 2000)
Variable | Men | Women | ||
1995 | 2000 | 1995 | 2000 | |
(N = 1,216) | (N = 987) | (N = 1,041) | (N = 838) | |
Age (years, mean ± SD) | 67 ± 10 | 66 ± 11 | 68 ± 9 | 68 ± 10 |
Ever Smoker (%) | 68 | 72 | 53 | 57 |
LVEF (%, mean ± SD) | 33 ± 15 | 33 ± 15 | 41 ± 17 | 41 ± 17 |
Missing (%) | 54 | 46 | 56 | 50 |
Documented Medical History (%) | ||||
Hypertension | 62 | 68 | 67 | 74 |
Diabetes | 35 | 37 | 36 | 40 |
Coronary Artery Disease | 59 | 63 | 43 | 51 |
Congestive Heart Failure | 65 | 69 | 59 | 70 |
In-Hospital Medication (%) | ||||
ACE Inhibitor | 62 | 65 | 57 | 55 |
Beta Blocker | 19 | 54 | 20 | 50 |
Spironolactone | 3 | 22 | 3 | 17 |
Discharge Medication (%) | ||||
ACE Inhibitor | 53 | 56 | 47 | 47 |
Beta Blocker | 13 | 45 | 13 | 42 |
Spironolactone | 2 | 19 | 1 | 16 |
Length of Hospital Stay (days, median, Q1–Q3) | 5,3–8 | 5,3–8 | 5,3–9 | 5,3–8 |
Mortality (%) | ||||
30 days | 14 | 9 | 10 | 9 |
6 months | 27 | 21 | 21 | 18 |
1 year | 36 | 28 | 27 | 27 |
LVEF = left ventricular ejection fraction;
ACE = angiotensin converting enzyme